DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Estramustine

Estramustine

  • Interactions with PBC Agents

    Interactions with PBC Agents

  • (12) United States Patent (10) Patent No.: US 9.498,431 B2 Xu Et Al

    (12) United States Patent (10) Patent No.: US 9.498,431 B2 Xu Et Al

  • Preferred Drug List 4-Tier

    Preferred Drug List 4-Tier

  • Antimicrotubule Effects of Estramustine, an Antiprostatic Tumor Drug

    Antimicrotubule Effects of Estramustine, an Antiprostatic Tumor Drug

  • Order in Council 1243/1995

    Order in Council 1243/1995

  • Emcyt® Estramustine Phosphate Sodium Capsules DESCRIPTION

    Emcyt® Estramustine Phosphate Sodium Capsules DESCRIPTION

  • 2021 Formulary List of Covered Prescription Drugs

    2021 Formulary List of Covered Prescription Drugs

  • Binding Characteristics of a Major Protein in Rat Ventral Prostate Cytosol That Interacts with Estramustine, a Nitrogen Mustard Derivative of 17ß-Estradiol

    Binding Characteristics of a Major Protein in Rat Ventral Prostate Cytosol That Interacts with Estramustine, a Nitrogen Mustard Derivative of 17ß-Estradiol

  • OUH Formulary Approved for Use in Breast Surgery

    OUH Formulary Approved for Use in Breast Surgery

  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

    Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

  • Pharmaceutical Composition and Dosage Forms for Administration of Hydrophobic Drugs

    Pharmaceutical Composition and Dosage Forms for Administration of Hydrophobic Drugs

  • Anatomical Classification Guidelines V2021 EPHMRA ANATOMICAL CLASSIFICATION GUIDELINES 2021

    Anatomical Classification Guidelines V2021 EPHMRA ANATOMICAL CLASSIFICATION GUIDELINES 2021

  • PHARMACEUTICAL APPENDIX to the HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2008) (Rev

    PHARMACEUTICAL APPENDIX to the HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2008) (Rev

  • Estradiol for the Mitigation of Adverse Effects of Androgen Deprivation Therapy

    Estradiol for the Mitigation of Adverse Effects of Androgen Deprivation Therapy

  • Environmentally Classified Pharmaceuticals 2014-2015

    Environmentally Classified Pharmaceuticals 2014-2015

  • Estramustine Sodium Phosphate Capsules BP

    Estramustine Sodium Phosphate Capsules BP

  • Controversies in the Management of Advanced Prostate Cancer

    Controversies in the Management of Advanced Prostate Cancer

  • Stembook 2018.Pdf

    Stembook 2018.Pdf

Top View
  • Appendix B - Product Name Sorted by Applicant
  • Estramustine Depolymerizes Microtnbules by Binding to Tubulin 1
  • Estramustine (Emcyt®) (“Es Tra MUS Teen”)
  • Hazardous Drug Acknowledgement Statement
  • Comparative Antitumor Effects of Hormonal Ablation, Estrogen
  • USP Class Example Part D Eligible Drugs* Salt/Ester
  • PRODUCT INFORMATION Estramustine Phosphate (Sodium Salt) Item No
  • Brand Generic Guide
  • Council of Europe Committee of Ministers (Partial
  • Administration of Estramustine in Response to Changes in the Prostate-Specific Antigen and Karnofsky Index in the Treatment of Prostate Cancer
  • 2021 Aetna Standard Plan
  • 2021 California Advantage Large Group 3-Tier HMO and PPO Prescription Drug List
  • Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
  • List of Off-Patent, Off-Exclusivity Drugs Without an Approved Generic
  • Jean-Philippe BESSE
  • Neoadjuvant Androgen Deprivation Therapy and Chemotherapy Followed by Radical Prostatectomy in Patients with Prostate Cancer
  • Known Bioactive Library: Microsource Discovery 1
  • September 2021 California Advantage Large Group 3-Tier PPO Prescription Drug List – CDI Version


© 2024 Docslib.org    Feedback